AFRO-NETS> Phase1 HIV vaccination trial to begin

[Gloria Katusiime <gkgloria@yahoo.com>]

Phase1 HIV vaccination trial to begin
-------------------------------------

By Gloria Katusiime, Kampala

Phase1 of the International AIDS Vaccine Initiative (IAVI) and Uganda 
Virus Research Institute (UVRI) vaccination trial is set to begin 
within the next few weeks.

Addressing journalists Tuesday, the principle investigator in the 
trial, Dr. Pontiano Kaleebu said the first vaccination should be car-
ried out in the next week.

The vaccine for the prevention of HIV infection (DNA-MVA) has been 
developed at the Uganda virus research institute in Entebbe. The aim 
of the trial is to test for its safety and immunogenicity.

This same vaccine is currently being tested in Kenya and the United 
Kingdom.

The IAVI-UVRI vaccination trial is the second to be carried out in 
Uganda after the first ALVAC trial by the Joint Clinical Research 
Centre ended in 2001.

Fifty volunteers are to enrol for the vaccination trial which is ex-
pected to last for 18 months.

Nzeera Ketter a consultant with IAVI added that this trial is just 
the beginning of a number of other trials to be carried out in Af-
rica. Another trial is already in the pipeline to cover East and 
Southern Africa. 


--
Gloria Katusiime
mailto:gkgloria@yahoo.com

--
To send a message to AFRO-NETS, write to: afro-nets@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe afro-nets OR unsubscribe afro-nets
To contact a person, send a message to: afro-nets-help@usa.healthnet.org
Information and archives: http://www.afronets.org